Mae Fah Luang University Hospital(Bangkok)
Bangkok, Thailand
NCT Number: NCT01391156
The purpose of this study is to compare the efficacy of 3% Minoxidil lotion and 3% Minoxidil with 0.1% Finasteride lotion for 6 months in male pattern hair loss.
Looking for future studies?
Notify Me18 year–50 year
Male
Interventional
Phase 3
Bangkok, Thailand
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3% Minoxidil lotion apply two times a day
3% Minoxidil with 0.1% Finasteride lotion apply two times a day.
Time frame: baseline and 6 months
Total hair count on the vertex is measured on 1 cm2 circular area. The mean change in hair count is compared at baseline and 6 months.The significance of change is determined by Unpaired t Test.
Time frame: baseline and 6 months
Photographs of the vertex scalp are taken at baseline and 6 months. A panel of 3 dermatologists assesssed the change in hair growth using a 7-point scale.
Mae Fah Luang University Hospital
Other
Efficacy of 3% Minoxidil Versus Combined 3% Minoxidil and 0.1% Finasteride for Male Pattern Hair Loss: a Randomized, Double-blinded, Comparative Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07615608
Alopecia, Androgenetic Alopecia
Barcelona, Spain
View Trial DetailsNCT06924632
Alopecia, Androgenetic Alopecia
Kogarah, New South Wales, Australia
View Trial DetailsNCT07433933
Alopecia, Androgenetic Alopecia
Alcalá de Henares, Madrid, Spain
View Trial DetailsNCT06927960
Alopecia, Androgenetic Alopecia
Los Angeles, California, United States
View Trial Details